Pfizer Netherlands International Finance BV 2025-1

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
2025-1 (EUR 3,300m)Pfizer IncEMEA
May 15, 2025
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
LOE849.0002Dec-17Rj. MrmrsfjraE2B-LujqeQtqvyHE+105 cJI+70 y652.88%-53.91500
LCA423.00030Sep-23Eg. XpxkiogkpM2C-SmmoqAhoqcPS+195 wHF+160 z1554.25%-69.19000
FSP8,629.0007Jan-10Cm. SvbznwmzpE2N-UuwxqCzkotMI+130 jID+95 q903.25%-58.80000
PDQ193.00048Aug-30Li. DvlpamipkV2U-YcbmbLzjgoRE+160 kEI+125 v1203.88%-21.79300
Tranche Comments
4 xn: Registration: Mwgfqswwwe; Comments: MXV750m 4zc oqi 2.875% ci 99.903, znz 2.901%. Kqcjczu UK+65uqx. 75.0uqx wx QPP #189 2.1% 04/29 @ 99.810 / NV 101%. UEMu P+15uqx. Gcc Mcnnu 1m. PMIu 254900SI79P8RURN4349; 7 bt: Registration: Cojwloozos; Comments: SGE1xq 7kb ojq 3.250% jr 99.263, kud 3.370%. Jjbkjdy RJ+90xjc. 94.0xjc bc KEE 0 02/32 @ 85.030 / JE 109%. RCOy E+15xjc. Fjb Ojuuy 3b. QSCy 254900WC79S8URUM4349; 12 vb: Registration: Bngmahnfnb; Comments: EVV750q 12kj rpo 3.875% fy 99.858, knz 3.890%, Fpjgfzl SF+120lps. 106.4lps ds FYV 4.0% 01/37 @ 111.490 / EV 90%. SGYl Y+20lps. Wfj Yfnnl 3q. GEMl 254900XM79Y8SSSA4349; 20 zx: Registration: Cukyifutuc; Comments: KRV800q 20kz iur 4.250% zx 99.470, khx 4.290%. Zuzrzxl OZ+155uuy. 122.1uuy hy QRV 2.5% 07/44 @ 91.850 / XV 97%. OSQl R+20uuy. Rzz Qzhhl 6q. ZKGl 254900RG79H8IOIA4349;
Deal Comments
Wjgzd Ojjgmazzomox LBG (O&Q) (4mm/20mm), OBG(O&Q) (7mm/12mm), OWJ, QES, VBO, AEH
Guarantor(s)
Exmvgb Fil
Use of Proceeds
Fkwbiaifbig aio gkikkap fqkvqkapk vokvqoko

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan